“Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?

The COVID-19 (coronavirus disease-2019) pandemic has presented unprecedented challenges to regulatory organizations, the biotech and pharmaceutical industry, and the publishing industry. This Translational Perspectives paper attempts to highlight some of the challenges and perils of moving extraordi...

Descripción completa

Detalles Bibliográficos
Autor principal: Van Norman, Gail A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
TRANSLATIONAL PERSPECTIVE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393415/
https://www.ncbi.nlm.nih.gov/pubmed/32760859
http://dx.doi.org/10.1016/j.jacbts.2020.06.001
Descripción
Sumario:The COVID-19 (coronavirus disease-2019) pandemic has presented unprecedented challenges to regulatory organizations, the biotech and pharmaceutical industry, and the publishing industry. This Translational Perspectives paper attempts to highlight some of the challenges and perils of moving extraordinarily fast in an effort to save human lives in the midst of a global pandemic. As with the development of all new therapeutic approaches, it will take time to assess the risks and benefits of developing new therapies at “warp speed”.

Ejemplares similares